Philadelphia positive acute lymphocytic leukaemia
Not recruitingStudy on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Study on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Disease:Philadelphia positive acute lymphocytic leukaemia
- Substances:BlinatumomabCalcium Levofolinate+14
Italy- Participants:18–64 years · 65+ years
- Substances:Blinatumomab
- Sponsor:Fondazione Gimema Franco Mandelli Onlus











